John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$332M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$309M |
| 3 |
Nike
NKE
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$209M |
| 5 |
Target
TGT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$238M |
| 2 |
PCGU
PG&E Corporation
PCGU
|
+$218M |
| 3 |
ConocoPhillips
COP
|
+$185M |
| 4 |
Amazon
AMZN
|
+$165M |
| 5 |
Cigna
CI
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.77% |
| 2 | Healthcare | 13.86% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.24% |
| 5 | Financials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Bruker
BRKR
$8.68B
| $5.85M | 0.01% |
79,160
-26,478
| -25% | -$2.02M |
|
827
Pliant Therapeutics
PLRX
$70.6M
| $5.79M | 0.01% |
319,286
-97,364
| -23% | -$2.3M |
|
828
Newell Brands
NWL
$2.59B
| $5.74M | 0.01% |
+660,213
| New | +$6.57M |
|
|
AMRN
829
Amarin Corp
AMRN
$292M
| $5.74M | 0.01% |
241,322
-36,727
| -13% | -$943K |
|
830
Varex Imaging
VREX
$781M
| $5.74M | 0.01% |
243,583
+34,441
| +16% | +$717K |
|
831
Pacira BioSciences
PCRX
$991M
| $5.74M | 0.01% |
143,222
+117,938
| +466% | +$4.88M |
|
832
Brookdale Senior Living
BKD
$2.89B
| $5.73M | 0.01% |
1,356,712
+379,634
| +39% | +$1.47M |
|
833
Four Corners Property Trust
FCPT
$2.8B
| $5.72M | 0.01% |
225,354
-10,955
| -5% | -$283K |
|
834
Apogee Enterprises
APOG
$863M
| $5.71M | 0.01% |
120,376
+31,722
| +36% | +$1.32M |
|
|
RNAM
835
DELISTED
Avidity Biosciences
RNAM
| $5.71M | 0.01% |
514,821
+186,333
| +57% | +$2.34M |
|
836
LeMaitre Vascular
LMAT
$1.83B
| $5.71M | 0.01% |
84,811
+37,752
| +80% | +$2.3M |
|
837
Manitowoc
MTW
$710M
| $5.69M | 0.01% |
302,239
-48,126
| -14% | -$777K |
|
838
A10 Networks
ATEN
$1.83B
| $5.67M | 0.01% |
388,886
-49,857
| -11% | -$721K |
|
|
ESMT
839
DELISTED
EngageSmart, Inc.
ESMT
| $5.62M | 0.01% |
294,515
-270,394
| -48% | -$4.81M |
|
840
Deere & Co
DE
$175B
| $5.62M | 0.01% |
13,869
+12,852
| +1,264% | +$4.91M |
|
841
Magnite
MGNI
$3.38B
| $5.59M | 0.01% |
409,830
+217,568
| +113% | +$2.42M |
|
842
Teva Pharmaceuticals
TEVA
$43B
| $5.59M | 0.01% |
742,793
-406,156
| -35% | -$3.29M |
|
843
Stem
STEM
$52.6M
| $5.59M | 0.01% |
48,881
-21,845
| -31% | -$2.17M |
|
844
Invesco Mortgage Capital
IVR
$805M
| $5.58M | 0.01% |
486,636
+458,436
| +1,626% | +$4.9M |
|
845
iShares US Healthcare Providers ETF
IHF
$1.24B
| $5.58M | 0.01% |
109,000
+57,000
| +110% | +$2.88M |
|
846
GFL Environmental
GFL
$15B
| $5.57M | 0.01% |
143,505
+109,000
| +316% | +$3.96M |
|
|
IPXXU
847
DELISTED
Inflection Point Acquisition Corp. II Unit
IPXXU
| $5.57M | 0.01% |
+550,000
| New | +$5.56M |
|
|
PWSC
848
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $5.56M | 0.01% |
290,439
+55,133
| +23% | +$1.05M |
|
849
Blue Bird Corp
BLBD
$1.87B
| $5.51M | 0.01% |
245,177
+229,177
| +1,432% | +$4.9M |
|
850
PUT
Green Plains
GPRE
$1.05B
| $5.51M | 0.01% |
170,800
+120,800
| +242% | +$3.83M |
|
Similar funds
John Overdeck's Q2 2023 Portfolio in Review
As of Q2 2023, John Overdeck held 3,452 positions worth $39.9B, up 14% from $35B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
John Overdeck deployed $2.46B of net new capital in Q2 2023, opening 521 new positions and adding to 1,149 existing holdings. Its largest new stake was Nike: 2,150,643 shares worth $237M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Netflix, an estimated $238M trimmed.
- John Overdeck's largest Q2 2023 buy was Nike: 2,150,643 shares worth $237M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $332M increase.
- John Overdeck's biggest Q2 2023 reduction was Netflix, cutting an estimated $238M.
- John Overdeck fully exited Goldman Sachs in Q2 2023, selling an estimated $127M.
- John Overdeck's ten largest holdings make up 7.6% of its $39.9B portfolio in Q2 2023.
- John Overdeck opened 521 new positions and closed 479 in Q2 2023.
- John Overdeck's portfolio value rose 14% quarter-over-quarter to $39.9B.
Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.